Search results for "Informatics"

showing 10 items of 2542 documents

Chances in the Brain Cells, From Epigenetic To the Future

2014

Copyright: © 2014 Valles SL. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Both oxidative damage and inflammation are elevated in brain from neurodegenerative patients [1], but their pathogenic significance remains unclear. Central nervous system has its own resident immune system, in which glial cells not only serve such as supportive and nutritive roles for neuron cells, also engage in several inflammatory processes that defend the central nervous system from pathogens and help it to recover from stres…

Central nervous systemEpiphenomenonInflammationBiologyBioinformaticsmedicine.disease_causemedicine.anatomical_structureImmune systemBystander effectmedicineEpigeneticsNeuronmedicine.symptomNeuroscienceOxidative stressGene Technology
researchProduct

CNS involvement in OFD1 syndrome: a clinical, molecular, and neuroimaging study

2014

Background Oral-facial-digital type 1 syndrome (OFD1; OMIM 311200) belongs to the expanding group of disorders ascribed to ciliary dysfunction. With the aim of contributing to the understanding of the role of primary cilia in the central nervous system (CNS), we performed a thorough characterization of CNS involvement observed in this disorder. Methods A cohort of 117 molecularly diagnosed OFD type I patients was screened for the presence of neurological symptoms and/or cognitive/behavioral abnormalities on the basis of the available information supplied by the collaborating clinicians. Seventy-one cases showing CNS involvement were further investigated through neuroimaging studies and neur…

Central nervous systemNeuroimagingNeuropsychological TestsPharmacologyBioinformaticsSettore MED/03 - GENETICA MEDICACiliopathiesCohort Studies03 medical and health sciences0302 clinical medicineNeuroimagingCentral Nervous System DiseasesmedicineHumansGenetics(clinical)Pharmacology (medical)Orofaciodigital type 1Ciliopathies; Neurodevelopmental phenotype; Neuroimaging; OFD1; Central Nervous System Diseases; Cohort Studies; Female; Humans; Magnetic Resonance Imaging; Mutation; Neuropsychological Tests; Orofaciodigital Syndromes; Medicine (all); Genetics (clinical); Pharmacology (medical)Agenesis of the corpus callosumGenetics (clinical)030304 developmental biologyMedicine(all)0303 health sciencesbusiness.industryMedicine (all)ResearchCiliumNeuropsychologyCognitionGeneral MedicineOrofaciodigital Syndromesmedicine.diseasecentral nervous systemMagnetic Resonance ImagingPorencephalyCiliopathies3. Good healthmedicine.anatomical_structureMutationFemaleNeurodevelopmental phenotypeOFD1business030217 neurology & neurosurgeryOrphanet Journal of Rare Diseases
researchProduct

Evidence of a chromosomal polymorphism unique to Cercopithecini. A key factor in the Tribe definition ?

2015

CercopithecinibiologyEvolutionary biologyTribeChromosomal Polymorphism; Cercopithecini; TribeChromosomal polymorphismSettore BIO/08 - AntropologiaChromosomal PolymorphismBioinformaticsbiology.organism_classificationCercopitheciniJournal of Primatology
researchProduct

Exploring hospital certification processes from the certification body’s perspective – a qualitative study

2020

Abstract Background Hospital certification is an external assessment mechanism to assure quality and safety systems. Auditors representing the certification body play a key role in certification processes, as they perform the assessment activities and interact with the involved healthcare organizations. There is limited knowledge about the approaches and methods that auditors use, such as role repertoire, conduct, and assessment practice. The purpose of this study was to explore auditors’ practice in hospital certification processes, guided by the following research questions: What styles do auditors apply in hospital certification processes, and how do auditors perceive their role in hospi…

CertificationISO 9001Surveyormedia_common.quotation_subjectObservationAuditCertificationHealth informaticsHealth administrationInterviews as Topic03 medical and health sciences0302 clinical medicineAuditorHealth careHumansMedicineExternal assessmentQuality (business)030212 general & internal medicineQualitative Researchmedia_commonMedical education:Medisinske Fag: 700::Helsefag: 800 [VDP]Norwaybusiness.industry030503 health policy & servicesHealth PolicyNursing researchlcsh:Public aspects of medicineReproducibility of Resultslcsh:RA1-1270HospitalsVDP::Medisinske Fag: 700::Helsefag: 800VDP::Medisinske Fag: 700::Helsefag: 800::Sykepleievitenskap: 8080305 other medical sciencebusinessQualitative researchResearch Article
researchProduct

Endringskapasitet – en nøkkel for å lykkes med gevinstrealisering i spesialisthelsetjenesten? : En studie av hvordan mellomledere opplever at endring…

2018

Masteroppgave i helse- og sosialinformatikk HSI500 - Universitetet i Agder 2018 Background: If an organisation is to reap the potential benefits of new technology, it must modify its work processes. However, the specialist health service appears to be experiencing significant challenges because it is constantly under pressure to change and improve its efficiency. This can weaken its capacity for change and, at worst, lead to long-term reductions in productivity and efficiency. Purpose: The purpose of this study is to examine how middle managers in the specialist health service feel they can influence developments in change capacity. The aim is to contribute to an awareness of the importance…

Change capacityHealth informaticsEndringskapasitetmellomlederehelseinformatikk.HSI500Middle managementgevinstrealiseringOrganisational changeBenefits managementorganisasjonsendringVDP::Teknologi: 500::Informasjons- og kommunikasjonsteknologi: 550VDP::Samfunnsvitenskap: 200::Statsvitenskap og organisasjonsteori: 240
researchProduct

Liquid Biopsy in Cancer Patients: The Hand Lens to Investigate Tumor Evolution

2017

In recent years the treatment of cancer patients has profoundly changed due to a better comprehension of the biological processes underlying tumor development and progression. Several tumors are defined as “oncogene addicted” and this discovery has led the way to the development of target therapies that are able to specifically kill cancer cells sparing normal cells from toxicity. Nowadays treatment decision is strictly dependent on the molecular characterization of the tumor; thus the path of cancer patients’ survival is tissue dependent but this may have several limitations. Indeed a single tissue biopsy represents only a snapshot limited in time and space but we are learning that tumor e…

Change over timePathologymedicine.medical_specialtyOncogenebusiness.industryCancer cellMedicineTreatment decision makingTarget therapyLiquid biopsybusinessBioinformaticsTissue biopsy
researchProduct

Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Disso…

2020

Dissolution is a crucial process for the oral delivery of drug products. Before being absorbed through epithelial cell membranes to reach the systemic circulation, drugs must first dissolve in the human gastrointestinal (GI) tract. In vivo and in vitro dissolutions are complex because of their dependency upon the drug physicochemical properties, drug product, and GI physiological properties. However, an understanding of this process is critical for the development of robust drug products. To enhance our understanding of in vivo and in vitro dissolutions, a hierarchical mass transfer (HMT) model was developed that considers the drug properties, GI fluid properties, and fluid hydrodynamics. T…

Chemistry PharmaceuticalDiffusionPharmaceutical Science02 engineering and technologyBuffers030226 pharmacology & pharmacyDiffusion03 medical and health sciences0302 clinical medicineMass transferDrug DiscoveryDissolution testingParticle SizeSolubilityDissolutionChemistryCheminformaticsHydrogen-Ion Concentration021001 nanoscience & nanotechnologyShear rateDrug LiberationKineticsModels ChemicalSolubilityChemical engineeringHydrodynamicsMolecular MedicineParticleParticle size0210 nano-technologyMolecular Pharmaceutics
researchProduct

2-[(1-Methyl-1H-pyrrol-2-yl)carbonyl-meth-yl]isoindoline-1,3-dione.

2009

The asymmetric unit of the title compound, C15H12N2O3, contains two almost identical molecules forming an nearly C2-symmetric dimeric pattern. The dihedral angles between the pyrrole ring and the phthalimide unit are 82.95 (8) and 86.57 (8)° for the two molecules. Within such a dimer, the phthalimide units of the two molecules form a dihedral angle of 1.5 (5)°.

ChemistryDimerGeneral ChemistryMeth-IsoindolineDihedral angleCondensed Matter PhysicsBioinformaticsRing (chemistry)Medicinal chemistryOrganic Paperslcsh:ChemistryPhthalimidechemistry.chemical_compoundlcsh:QD1-999General Materials SciencePyrroleActa crystallographica. Section E, Structure reports online
researchProduct

6-Amino-1-benzyl-4-(4-chloro-phen-yl)-3-(4-pyrid-yl)-1,4-dihydro-pyrano[2,3-c]pyrazole-5-carbonitrile.

2008

The crystal structure of the title compound, C25H18ClN5O, was determined in the course of our studies on the synthesis of 1,4-dihydropyrano[2,3-c]pyrazole as an inhibitor of the p38 mitogen-activated protein kinase (MAPK). The compound was prepared via a base-catalysed synthesis from 1-benzyl-3-(4-pyridyl)-1H-pyrazol-5(4H)-one with p-chloroaldehyde and malononitrile. The crystal data obtained were used to generate a three-dimensional pharmacophore model for in silico database screening. The phenyl ring is disordered over two positions, with site occupancy factors of 0.55 and 0.45. The dihedral angles between the 1,4-dihydropyrano[2,3-c]pyrazole unit and the chlorophenyl and pyridine rings a…

ChemistryGeneral ChemistryCrystal structureDihedral anglePyrazoleCondensed Matter PhysicsRing (chemistry)BioinformaticsMedicinal chemistryOrganic Paperslcsh:Chemistrychemistry.chemical_compoundlcsh:QD1-999Crystal dataPyridineGeneral Materials SciencePharmacophoreMalononitrileActa crystallographica. Section E, Structure reports online
researchProduct

A triclinic polymorph of (−)-(S)-N-benzyl-2-[(R)-6-fluorochroman-2-yl]-2-hydroxyethanaminium bromide

2013

The title salt, C18H21FNO2+·Br−, determined at 115 K, crystallizes in the triclinic space groupP1. The previously reported polymorph occurs in the monoclinic space groupP21and has two independent molecules in the asymmetric unit [Peeterset al.(1993).Acta Cryst.C49, 2157–2160]. In the title molecule, the pyran rings adopt half-chair conformations. The absolute configuration isSfor the hydroxy-bearing C atom andRfor the asymmetric C atom in the dihydropyran unit. In the crystal, the components are linked by N—H...Br and O—H...Br hydrogen bonds, forming chains along thec-axis direction. The crystal studied was refined as an inversion twin.

ChemistryHydrogen bondAbsolute configurationGeneral ChemistryTriclinic crystal systemCondensed Matter PhysicsBioinformaticsOrganic PapersCrystalCrystallographychemistry.chemical_compoundPyranBromideMoleculeGeneral Materials ScienceMonoclinic crystal systemActa Crystallographica Section E Structure Reports Online
researchProduct